Clicky

Beijing SL Pharmaceutical Co Ltd(002038)

Description: Beijing SL Pharmaceutical Co., Ltd., a biopharmaceutical company, researches, develops, produces, and markets genetic engineering and related drugs in the People's Republic of China and internationally. The company's finished formulations includes temozolomide; arsenic trioxide; lenalidomide; docetaxel; paclitaxel; filgrastim Recombinant human granulocyte colony-stimulating factor; recombinant human interleukin-11; recombinant human interleukin-2; thymopentin; vinorelbine bitartrate; hydroxyl-camptothecine; nimustine hydrochloride; asparaginase; PEG L-asparaginase; calcium foliate; recombinant human basic fibroblast growth factor; ciclosporin; mycophenolate mofetil dispersible; ornidazole; adefovir dipivoxil; levofloxacin hydrochloride; azithromycin; ribavirin; tenofovir disoproxil fumarate; valacylovir hydrochloride; lysozyme; stavudine; tropisetron hydrochloride; granisetron hydrochloride; omeprazole; ademetionine 1,4-butanedisulfonate; glutathione; enoxaparin sodium; coenzyme complex; ginkgo biloba extract; simvastatin; telmisartan; naftopidil; nicergoline; zaleplon; cytidine disodium triphosphate; febuxostat; risedronate sodium; loratadine dispersible; somatostatin; octreotide acetate; calcitonin (salmon); paracetamol and tramadol hydrochloride; and etodolac. It also offers active pharmaceutical ingredients. The company was formerly known as Beijing BaiLuyuan Bio-Pharmaceutical Co., Ltd and changed its name to Beijing SL Pharmaceutical Co., Ltd. in 1998. Beijing SL Pharmaceutical Co., Ltd. was founded in 1994 and is based in Beijing, the People's Republic of China.


Keywords: Biopharmaceutical Drugs Chemical Compounds Genetic Engineering Amines Recombinant Docetaxel Paclitaxel Paracetamol Levofloxacin Enoxaparin Sodium Omeprazole Ribavirin Azithromycin Glutathione Lenalidomide Somatostatin Telmisartan Adefovir Dipivoxil Ciclosporin Filgrastim Interleukin Loratadine Nicergoline Simvastatin Thymopentin

Home Page: www.slpharm.com.cn

Building 1, Bitongyuan
Beijing, 100049
China
Phone: 86 10 8862 7635


Officers

Name Title
Dr. Mingbo Xu Founder, Chairman & GM
Mr. Yajun Li Exec. Deputy GM & CFO
Ms. Shujie Liang Sec. & Non-Independent Director

Exchange: SHE

Country: CN

Currency: Renminbi (¥)

Forward PE: 0
Trailing PE: 38.5455
Price-to-Book MRQ: 1.7404
Price-to-Sales TTM: 8.5036
IPO Date: 2004-08-25
Fiscal Year End: December
Full Time Employees: 761
Back to stocks